Kelly Lawrence W & Associates’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
LP
Kelly Lawrence W & Associates's AGN Position: Q2 2019 in Review
Kelly Lawrence W & Associates sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 10,873 shares — an estimated $1.59M sold.
Kelly Lawrence W & Associates first reported a position in AGN in Q1 2015 and held it in 17 quarters. The position peaked at $10.6M in Q3 2018. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.
- Kelly Lawrence W & Associates reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
- Kelly Lawrence W & Associates sold 10,873 Allergan plc shares in Q2 2019, an estimated $1.59M.
- Kelly Lawrence W & Associates first reported a position in Allergan plc in Q1 2015 and held it in 17 quarters.
- Kelly Lawrence W & Associates's Allergan plc position peaked at $10.6M in Q3 2018.
- 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.
Based on Kelly Lawrence W & Associates's 13F filing for Q2 2019, filed 14 Aug 2019.